Volker Sandig
Chief Scientific Officer
Management
ProBioGen
Germany
Biography
CSO of ProBioGen since April 2010. Dr Volker Sandig established ProBioGen’s cell line development program in 2000, and has been responsible for the development of high producer cell lines and the customised design of new cell lines from primary sources. Prior to joining ProBioGen, he held senior management positions at Merck Research Laboratories, USA, focusing on the development of manufacturing systems for gutless adenoviruses. Using his knowledge of viral vectors, he also participated in Merck’s HIV vaccine program. Earlier in his career, he designed experimental strategies for adenovirus-based tumor treatment and directed research projects in cell cycle regulation and artificial promoters at the Max Planck Society and at Hepavec, a Berlin-based biotech company. After finishing medical training, Volker Sandig received his PhD in Molecular Biology from the Humboldt University, Berlin.
Research Interest
Molecular Biology
